Loading
 มารุตพงศ์  เดชอาญา

มารุตพงศ์ เดชอาญา

คณะแพทยศาสตร์,
มหาวิทยาลัยขอนแก่น
57205391929: H-INDEX 6

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Polypeptide N-acetylgalactosaminyltransferase 5 regulates growth and metastasis of cholangiocarcinoma Marutpong Detarya
Sriwipa Chuangchaiya
Lukkana Sukprasert
Atit Silsirivanit
Kanlayanee Sawanyawisuth
Sopit Wongkham
Chaisiri Wongkham
2018
2. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma Phoomak, C.
Silsirivanit, A.
Sawanyawisuth, K.
Vaeteewoottacharn, K.
Wongkham, C.
Wongkham, S.
2019
3. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling Marutpong Detarya
Kanlayanee Sawanyawisuth
Chaiwat Aphivatanasiri
Sriwipa Chuangchaiya
Paksiree Saranaruk
Lukkana Sukprasert
Atit Silsirivanit
Norie Araki
Sopit Wongkham
Chaisiri Wongkham
2020
4. Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus Charupong Saengboonmee
Wunchana Seubwai
Sakkarn Sangkhamanon
Marutpong Detarya
Kanlayanee Sawanyawisuth
Atit Silsirivanit
Sopit Wongkham
2021
5. FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients. Seubwai, W.
Sawanyawisuth, K.
Lert-Itthiporn, W.
Waraasawapati, S.
Wongkham, S.
2021
6. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus. Charupong Saengboonmee
Marutpong Detarya
Sakkarn Sangkhamanon
Kanlayanee Sawanyawisuth
Wunchana Seubwai
Sopit Wongkham
2021
7. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma Seubwai, W.
Phoomak, C.
Saengboonmee, C.
Wongkham, S.
Wongkham, C.
2021
8. Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight. Detarya, M
Lert-Itthiporn, W
Mahalapbutr, P
Klaewkla, M
Sorin, S
Sawanyawisuth, K
Silsirivanit, A
Seubwai, W
Wongkham, C
Araki, N
Wongkham, S
2022
9. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus Saengboonmee, C.
Sawanyawisuth, K.
Seubwai, W.
Wongkham, S.
2022
10. Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis. Thamrongwaranggoon, U.
Seubwai, W.
Saengboonmee, C.
Wongkham, S.
2022
11. Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor Obchoei, S
Detarya, M
Boonnate, P
Saranaruk, P
Vaeteewoottacharn, K
Mahalapbutr, P
Okada, S
Wongkham, S
2022
12. Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma. Panawan, O
Silsirivanit, A
Chang, CH
Putthisen, S
Boonnate, P
Yokota, T
Nishisyama-Ikeda, Y
Detarya, M
Sawanyawisuth, K
Kaewkong, W
Muisuk, K
Luang, S
Vaeteewoottacharn, K
Kariya, R
Yano, H
Komohara, Y
Ohta, K
Okada, S
Wongkham, S
Araki, N
2023
13. Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insight. Detarya, M. 2023
14. Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma. Phuyathip, W.
Putthisen, S.
Panawan, O.
Ma-In, P.
Teeravirote, K.
Sintusen, P.
Udomkitkosol, S.
Detarya, M.
2024
Count 9 10 7 0

Title Authors Year Publication name Cited count
< 2020 2021 2022 2023 2024 2025 รวม
1. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma Phoomak, C.
Silsirivanit, A.
Sawanyawisuth, K.
Vaeteewoottacharn, K.
Wongkham, C.
Wongkham, S.
2019 Molecular Oncology
2 (13), pp. 338-357
2. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling Sawanyawisuth, K.
Silsirivanit, A.
Wongkham, S.
Wongkham, C.
2020 Glycobiology
5 (30), pp. 312-324
3. FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients Seubwai, W.
Sawanyawisuth, K.
Lert-Itthiporn, W.
Waraasawapati, S.
Wongkham, S.
2021 Heliyon
4 (7), pp.
4. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma Seubwai, W.
Phoomak, C.
Saengboonmee, C.
Wongkham, S.
Wongkham, C.
2021 Life Sciences
(271), pp.
5. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus Saengboonmee, C.
Sawanyawisuth, K.
Seubwai, W.
Wongkham, S.
2022 Nutrition and Cancer
5 (74), pp. 1734-1744
6. Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis Thamrongwaranggoon, U.
Seubwai, W.
Saengboonmee, C.
Wongkham, S.
2022 Life Sciences
(302), pp.
7. Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor Obchoei, S.
Detarya, M.
Boonnate, P.
Saranaruk, P.
Vaeteewoottacharn, K.
Mahalapbutr, P.
Wongkham, S.
2022 Asian Pacific Journal of Cancer Prevention
10 (23), pp. 3379-3386
8. Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insight Detarya, M. 2023 Biochimica et Biophysica Acta - General Subjects
12 (1867), pp.
9. Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma Phuyathip, W.
Putthisen, S.
Panawan, O.
Ma-In, P.
Teeravirote, K.
Sintusen, P.
Udomkitkosol, S.
Detarya, M.
2024 Histochemistry and Cell Biology
5 (161), pp. 423-434

Title Authors Year Journal title
1. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma. Phoomak, C
Park, D
Silsirivanit, A
Sawanyawisuth, K
Vaeteewoottacharn, K
Detarya, M
Wongkham, C
Lebrilla, CB
Wongkham, S
2019 Molecular oncology
2 (13), pp. 338-357
2. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling. Detarya, M
Sawanyawisuth, K
Aphivatanasiri, C
Chuangchaiya, S
Saranaruk, P
Sukprasert, L
Silsirivanit, A
Araki, N
Wongkham, S
Wongkham, C
2020 Glycobiology
5 (30), pp. 312-324
3. FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients. Klinhom-On, N
Seubwai, W
Sawanyawisuth, K
Lert-Itthiporn, W
Waraasawapati, S
Detarya, M
Wongkham, S
2021 Heliyon
4 (7), pp. e06846
4. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus. Saengboonmee, C
Detarya, M
Sangkhamanon, S
Sawanyawisuth, K
Seubwai, W
Wongkham, S
2021 Nutrition and cancer
(), pp. 1-11
5. Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis. Thamrongwaranggoon, U
Detarya, M
Seubwai, W
Saengboomee, C
Hino, S
Koga, T
Nakao, M
Wongkham, S
2022 Life sciences
(), pp. 120648
6. Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight. Detarya, M
Lert-Itthiporn, W
Mahalapbutr, P
Klaewkla, M
Sorin, S
Sawanyawisuth, K
Silsirivanit, A
Seubwai, W
Wongkham, C
Araki, N
Wongkham, S
2022 American journal of cancer research
9 (12), pp. 4140-4159
7. Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor. Obchoei, S
Detarya, M
Boonnate, P
Saranaruk, P
Vaeteewoottacharn, K
Mahalapbutr, P
Okada, S
Wongkham, S
2022 Asian Pacific journal of cancer prevention : APJCP
10 (23), pp. 3379-3386
8. Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma. Panawan, O
Silsirivanit, A
Chang, CH
Putthisen, S
Boonnate, P
Yokota, T
Nishisyama-Ikeda, Y
Detarya, M
Sawanyawisuth, K
Kaewkong, W
Muisuk, K
Luang, S
Vaeteewoottacharn, K
Kariya, R
Yano, H
Komohara, Y
Ohta, K
Okada, S
Wongkham, S
Araki, N
2023 Cancer science
8 (114), pp. 3230-3246
9. Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insight. Detarya, M
Mahalapbutr, P
Waenphimai, O
Kidoikhammouan, S
Janeklang, S
Sawanyawisuth, K
Vaeteewoottacharn, K
Seubwai, W
Saengboonmee, C
Thothaisong, T
Pabuprapap, W
Suksamrarn, A
Wongkham, S
2023 Biochimica et biophysica acta. General subjects
12 (1867), pp. 130486
10. Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma. Phuyathip, W
Putthisen, S
Panawan, O
Ma-In, P
Teeravirote, K
Sintusen, P
Udomkitkosol, S
Detarya, M
Luang, S
Mahalapbutr, P
Sato, T
Kuno, A
Chuangchaiya, S
Silsirivanit, A
2024 Histochemistry and cell biology
5 (161), pp. 423-434

Title Authors Year Journal title Cited count
< 2020 2021 2022 2023 2024 2025 รวม
1. Polypeptide N-acetylgalactosaminyltransferase 5 regulates growth and metastasis of cholangiocarcinoma Marutpong Detarya
Sriwipa Chuangchaiya
Lukkana Sukprasert
Atit Silsirivanit
Kanlayanee Sawanyawisuth
Sopit Wongkham
Chaisiri Wongkham
2018 CANCER SCIENCE
(109.0), pp. 257.0-257.0
0 0 0 0 0 0 0
2. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma Chatchai Phoomak
Dayoung Park
Atit Silsirivanit
Kanlayanee Sawanyawisuth
Kulthida Vaeteewoottacharn
Marutpong Detarya
Chaisiri Wongkham
Carlito B. Lebrilla
Sopit Wongkham
2019 MOLECULAR ONCOLOGY
2.0 (13.0), pp. 338.0-357.0
20 0 0 0 0 0 20
3. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling Marutpong Detarya
Kanlayanee Sawanyawisuth
Chaiwat Aphivatanasiri
Sriwipa Chuangchaiya
Paksiree Saranaruk
Lukkana Sukprasert
Atit Silsirivanit
Norie Araki
Sopit Wongkham
Chaisiri Wongkham
2020 GLYCOBIOLOGY
5.0 (30.0), pp. 312.0-324.0
11 0 0 0 0 0 11
4. Cyclin A is upregulated by high glucose and a potential target for cholangiocarcinoma patients with diabetes mellitus Charupong Saengboonmee
Wunchana Seubwai
Sakkarn Sangkhamanon
Marutpong Detarya
Kanlayanee Sawanyawisuth
Atit Silsirivanit
Sopit Wongkham
2021 CANCER SCIENCE
(112.0), pp. 540.0-540.0
0 0 0 0 0 0 0
5. FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients Nathakan Klinhom-on
Wunchana Seubwai
Kanlayanee Sawanyawisuth
Worachart Lert-itthiporn
Sakda Waraasawapati
Marutpong Detarya
Sopit Wongkham
2021 HELIYON
4.0 (7.0), pp.
1 0 0 0 0 0 1
6. High Glucose Induced Upregulation of Cyclin a Associating with a Short Survival of Patients with Cholangiocarcinoma: A Potential Target for Treatment of Patients with Diabetes Mellitus Charupong Saengboonmee
Marutpong Detarya
Sakkarn Sangkhamanon
Kanlayanee Sawanyawisuth
Wunchana Seubwai
Sopit Wongkham
2021 NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
(), pp.
0 0 0 0 0 0 0
7. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma Marutpong Detarya
Salak Thaenkaew
Wunchana Seubwai
Somsiri Indramanee
Chatchai Phoomak
Charupong Saengboonmee
Sopit Wongkham
Chaisiri Wongkham
2021 LIFE SCIENCES
(271.0), pp.
0 0 0 0 0 0 0

Title Authors Year Journal title

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ

0.05853915214538574